| Assay ID | Title | Year | Journal | Article |
|---|
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID329131 | Inhibition of ToxT-mediated transcriptional activation of acfA promoter in Vibrio cholerae O395deltalacZ assessed as beta-galactosidase expression at 100 uM relative to control | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID1785051 | Inhibition of ToxT in Vibrio cholerae at upto 5 uM measured after 3.5 hrs by beta-galactosidase assay relative to control | 2021 | ACS medicinal chemistry letters, Sep-09, Volume: 12, Issue:9
| An Enantiodefined Conformationally Constrained Fatty Acid Mimetic and Potent Inhibitor of ToxT. |
| AID329122 | Inhibition of Vibrio cholerae wild type ToxT N-terminal domain dimerization expressed in Escherichia coli assessed as beta-galatosidase reporter gene expression at 35 uM by bacterial two-hybrid system | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID329126 | Inhibition of ToxT-mediated transcriptional activation of tcpA promoter in Vibrio cholerae O395deltalacZ assessed as beta-galactosidase expression at 100 uM relative to control | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID329128 | Inhibition of ToxT-mediated transcriptional activation of ctxAB promoter in Vibrio cholerae O395deltalacZ assessed as beta-galactosidase expression at 100 uM relative to control | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID977602 | Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM | 2013 | Molecular pharmacology, Jun, Volume: 83, Issue:6
| Structure-based identification of OATP1B1/3 inhibitors. |
| AID977599 | Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM | 2013 | Molecular pharmacology, Jun, Volume: 83, Issue:6
| Structure-based identification of OATP1B1/3 inhibitors. |
| AID329129 | Inhibition of ToxT-mediated transcriptional activation of tagA promoter in Vibrio cholerae O395deltalacZ assessed as beta-galactosidase expression at 100 uM relative to control | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID329133 | Inhibition of maltose binding protein-fused Vibrio cholerae ToxT monomer by gel filtration method | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID329120 | Inhibition of Vibrio cholerae wild type ToxT N-terminal domain dimerization expressed in Escherichia coli assessed as beta-galatosidase reporter gene expression at 10 uM by bacterial two-hybrid system | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID329127 | Inhibition of ToxT-mediated transcriptional activation of acfD promoter in Vibrio cholerae O395deltalacZ assessed as beta-galactosidase expression at 100 uM relative to control | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID329134 | Inhibition of maltose binding protein-fused Vibrio cholerae ToxT L113P mutant monomer by gel filtration method | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID329123 | Inhibition of Vibrio cholerae wild type ToxT N-terminal domain dimerization expressed in Escherichia coli assessed as beta-galatosidase reporter gene expression at 50 uM by bacterial two-hybrid system | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID329132 | Inhibition of ToxT-mediated transcriptional activation of aldA promoter in Vibrio cholerae O395deltalacZ assessed as beta-galactosidase expression at 100 uM relative to control | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID329124 | Inhibition of Vibrio cholerae ToxT L113P mutant N-terminal domain dimerization expressed in Escherichia coli assessed as beta-galatosidase reporter gene expression at 10 uM by bacterial two-hybrid system | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID329125 | Inhibition of Vibrio cholerae wild type ToxT-mediated transcription of ctx promoter at 50 uM | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID329130 | Inhibition of ToxT-mediated transcriptional activation of tcpI promoter in Vibrio cholerae O395deltalacZ assessed as beta-galactosidase expression at 100 uM relative to control | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID329121 | Inhibition of Vibrio cholerae wild type ToxT N-terminal domain dimerization expressed in Escherichia coli assessed as beta-galatosidase reporter gene expression at 20 uM by bacterial two-hybrid system | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Feb-13, Volume: 104, Issue:7
| Virstatin inhibits dimerization of the transcriptional activator ToxT. |
| AID1159550 | Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening | 2015 | Nature cell biology, Nov, Volume: 17, Issue:11
| 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |